219762-46-6

Basic information

• Product Name: 4-bromo-2-chloro-1-((methanesulfonyloxy)-methyl)benzene
• Synonyms: 4-bromo-2-chloro-1-((methanesulfonyloxy)-methyl)benzene
• CAS NO: 219762-46-6
• Molecular Weight: 299.573
• Mol File: 219762-46-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-bromo-2-chloro-1-((methanesulfonyloxy)-methyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-chloro-1-((methanesulfonyloxy)-methyl)benzene(219762-46-6)
• EPA Substance Registry System: 4-bromo-2-chloro-1-((methanesulfonyloxy)-methyl)benzene(219762-46-6)

Safety Data

• Hazardous Substances Data: 219762-46-6(Hazardous Substances Data)

Upstream product

• 185315-48-4 (4-bromo-2-chlorophenyl)methanol 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 219766-73-1 methyl 3-(4-bromo-2-chlorobenzyl)-2,7-dimethyl-3H-imidazo[4,5-b]pyridine-5-carboxylate 
• 219768-31-7 3-(2-chloro-4-ethylbenzyl)-2,7-dimethyl-3H-imidazo[4,5-b]pyridine-5-carboxylic acid 
• 219766-76-4 3-(4-bromo-2-chlorobenzyl)-2,7-dimethyl-3H-imidazo[4,5-b]pyridine-5-carboxylic acid 
• 219759-97-4 3-(4-bromo-2-chlorobenzyl)-2,7-dimethyl-5-[(4-methylbenzene)-sulfonyl-carbamoyl]-3H-imidazo[4,5-b]pyridine 

Relevant articles and documents

Sulfonamide compounds and uses thereof as medicines

The present invention relates to a sulfonamide compound of the formula (I): wherein each symbol is as defined in the specification, a salt thereof, and a pharmaceutical composition containing same. This compound can be an effective agent for the prophylaxis and treatment of the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle cell inhibitory action and an allergy suppressing action.

IMIDAZOLE COMPOUNDS AND MEDICINAL USE THEREOF

Imidazole compounds represented by general formula (I): wherein each symbol is as defined in the specification, and salts thereof, and a pharmaceutical composition containing same are provided. These compounds are useful in treating the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle cell inhibitory action and an allergy inhibitory action.